Sanchez, V; Angeletti, P C; Engler, J A et al. (1998) Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts. J Virol 72:3321-9
|
Fish, K N; Britt, W; Nelson, J A (1996) A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol 70:1855-62
|
Britt, W J (1996) Vaccines against human cytomegalovirus: time to test. Trends Microbiol 4:34-8
|
Li, L; Coelingh, K L; Britt, W J (1995) Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J Virol 69:6047-53
|
Fish, K N; Depto, A S; Moses, A V et al. (1995) Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol 69:3737-43
|
Boppana, S B; Polis, M A; Kramer, A A et al. (1995) Virus-specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis. J Infect Dis 171:182-5
|
Harrison, C J; Britt, W J; Chapman, N M et al. (1995) Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J Infect Dis 172:1212-20
|
Billstrom, M A; Britt, W J (1995) Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding. J Virol 69:7015-22
|
Britt, W; Fay, J; Seals, J et al. (1995) Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J Infect Dis 171:18-25
|
Britt, W J; Harrison, C (1994) Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus. Virology 201:294-302
|
Showing the most recent 10 out of 16 publications